Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors

Ruf, Theresa; Kramer, Rafaela; Forschner, Andrea; Leiter, Ulrike; Meier, Friedegund; Reinhardt, Lydia; Duecker, Pia; Ertl, Carolin; Tomsitz, Dirk; Tietze, Julia K.; Gutzmer, Ralf; Dabrowski, Evelyn; Zimmer, Lisa; Gesierich, Anja; Zierold, Sarah; French, Lars E.; Eigentler, Thomas; Amaral, Teresa; Heinzerling, Lucie

Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors

Autor(en):

Ruf, Theresa; Kramer, Rafaela; Forschner, Andrea; Leiter, Ulrike; Meier, Friedegund; Reinhardt, Lydia; Duecker, Pia; Ertl, Carolin; Tomsitz, Dirk; Tietze, Julia K.; Gutzmer, Ralf; Dabrowski, Evelyn; Zimmer, Lisa; Gesierich, Anja; Zierold, Sarah; French, Lars E.; Eigentler, Thomas; Amaral, Teresa; Heinzerling, Lucie

Tübinger Autor(en):

Forschner, Andrea
Leiter, Ulrike
Amaral, Teresa

Erschienen in:

European Journal of Cancer (2024), Bd. 203, Article 114028

Verlagsangabe:

London : Elsevier Sci Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.ejca.2024.114028

ISSN:

0959-8049